Personality traits and the R668Q polymorphism located in the MMP-9 gene

Behavioural Brain Research

Volumn 228, Issue 1, 2012, Pages 232-235

  Suchankova, Petra ^a   Pettersson, Robert ^a   Nordenström, Kajsa ^a   Holm, Göran ^a   Ekman, Agneta ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

5545G>A; Aggression; Karolinska Scales of Personality (KSP); Matrix metalloproteinase 9; R668Q; Rs17577

Indexed keywords

ARGININE; GELATINASE B; GLUTAMINE;

ADULT; AGGRESSION; AMINO ACID SUBSTITUTION; ARTICLE; COHORT ANALYSIS; ENZYME ACTIVITY; FEMALE; GENE; HUMAN; IRRITABILITY; MALE; MMP 9 GENE; PERSONALITY; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VERBAL HOSTILITY;

ADULT; AGGRESSION; FEMALE; GENOTYPE; HUMANS; IRRITABLE MOOD; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PERSONALITY; PERSONALITY INVENTORY; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS;

EID: 84855944972     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.026     Document Type: Article

References (52)

1. Candelario-Jalil E., Taheri S., Yang Y., Sood R., Grossetete M., Estrada E.Y., et al. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat. J Pharmacol Exp Ther 2007, 323:488-498.
2. Vitkovic L., Bockaert J., Jacque C. Inflammatory cytokines: neuromodulators in normal brain?. J Neurochem 2000, 74:457-471.
3. Rahpeymai Y., Hietala M.A., Wilhelmsson U., Fotheringham A., Davies I., Nilsson A.K., et al. Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J 2006, 25:1364-1374.
4. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol Rev 2008, 88:1183-1241.
5. Agrawal S.M., Lau L., Yong V.W. MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol 2008, 19:42-51.
6. Barkho B.Z., Munoz A.E., Li X., Li L., Cunningham L.A., Zhao X. Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines. Stem Cells 2008, 26:3139-3149.
7. Kaczmarek L., Lapinska-Dzwonek J., Szymczak S. Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?. EMBO J 2002, 21:6643-6648.
8. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., et al. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 2006, 26:1923-1934.
9. Wang X.B., Bozdagi O., Nikitczuk J.S., Zhai Z.W., Zhou Q., Huntley G.W. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proc Natl Acad Sci USA 2008, 105:19520-19525.
10. Leira R., Sobrino T., Rodriguez-Yanez M., Blanco M., Arias S., Castillo J. Mmp-9 immunoreactivity in acute migraine. Headache 2007, 47:698-702.
11. Imamura K., Takeshima T., Fusayasu E., Nakashima K. Increased plasma matrix metalloproteinase-9 levels in migraineurs. Headache 2008, 48:135-139.
12. Rybakowski J.K., Skibinska M., Kapelski P., Kaczmarek L., Hauser J. Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophr Res 2009, 109:90-93.
13. Opdenakker G., Nelissen I., Van Damme J. Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis. Lancet Neurol 2003, 2:747-756.
14. Wilczynski G.M., Konopacki F.A., Wilczek E., Lasiecka Z., Gorlewicz A., Michaluk P., et al. Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol 2008, 180:1021-1035.
15. Benekareddy M., Mehrotra P., Kulkarni V.A., Ramakrishnan P., Dias B.G., Vaidya V.A. Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus. Synapse 2008, 62:590-600.
16. Mizoguchi H., Yamada K., Mouri A., Niwa M., Mizuno T., Noda Y., et al. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release. J Neurochem 2007, 102:1548-1560.
17. Ebstein R.P., Benjamin J., Belmaker R.H. Personality and polymorphisms of genes involved in aminergic neurotransmission. Eur J Pharmacol 2000, 410:205-214.
18. Whittle S., Allen N.B., Lubman D.I., Yucel M. The neurobiological basis of temperament: towards a better understanding of psychopathology. Neurosci Biobehav Rev 2006, 30:511-525.
19. Alia-Klein N., Goldstein R.Z., Kriplani A., Logan J., Tomasi D., Williams B., et al. Brain monoamine oxidase A activity predicts trait aggression. J Neurosci 2008, 28:5099-5104.
20. Bouchard T.J., McGue M. Genetic and environmental influences on human psychological differences. J Neurobiol 2003, 54:4-45.
21. Murphy G., Knauper V. Relating matrix metalloproteinase structure to function: why the hemopexin domain?. Matrix Biol 1997, 15:511-518.
22. Cotignola J., Reva B., Mitra N., Ishill N., Chuai S., Patel A., et al. Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma. BMC Med Genet 2007, 8:10.
23. Nakashima K., Hirota T., Obara K., Shimizu M., Doi S., Fujita K., et al. A functional polymorphism in MMP-9 is associated with childhood atopic asthma. Biochem Biophys Res Commun 2006, 344:300-307.
24. Zhi H., Wang H., Ren L., Shi Z., Peng H., Cui L., et al. Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population. Mol Biol Rep 2010, 37:13-20.
25. Rosmond R., Bjorntorp P. Psychiatric ill-health of women and its relationship to obesity and body fat distribution. Obes Res 1998, 6:338-345.
26. Henningsson S., Hakansson A., Westberg L., Baghaei F., Rosmond R., Holm G., et al. Interleukin-6 gene polymorphism-174G/C influences plasma lipid levels in women. Obesity (Silver Spring) 2006, 14:1868-1873.
27. Rosmond R., Dallman M.F., Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998, 83:1853-1859.
28. Schalling D., Asberg M., Edman G., Oreland L. Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand 1987, 76:172-182.
29. Gustavsson J.P., Pedersen N.L., Asberg M., Schalling D. Origins of individual differences in anxiety proneness: a twin/adoption study of the anxiety-related scales from the Karolinska Scales of Personality (KSP). Acta Psychiatr Scand 1996, 93:460-469.
30. Gustavsson J.P., Weinryb R.M., Goransson S., Pedersen N.L., Asberg M. Stability and predictive ability of personality traits across 9 years. Pers Individ Dif 1997, 22:783-791.
31. Okulski P., Jay T.M., Jaworski J., Duniec K., Dzwonek J., Konopacki F.A., et al. TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol Psychiatry 2007, 62:359-362.
32. Brown T.E., Forquer M.R., Harding J.W., Wright J.W., Sorg B.A. Increase in matrix metalloproteinase-9 levels in the rat medial prefrontal cortex after cocaine reinstatement of conditioned place preference. Synapse 2008, 62:886-889.
33. Bozdagi O., Nagy V., Kwei K.T., Huntley G.W. In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J Neurophysiol 2007, 98:334-344.
34. Nagy V., Bozdagi O., Huntley G.W. The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory. Learn Mem 2007, 14:655-664.
35. Wright J.W., Brown T.E., Harding J.W. Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory. Neural Plast 2007, 2007:73813.
36. Rosenberg G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009, 8:205-216.
37. Nilsson T., Bromander S., Anckarsater R., Kristiansson M., Forsman A., Blennow K., et al. Neurochemical measures co-vary with personality traits: forensic psychiatric findings replicated in a general population sample. Psychiatry Res 2010, 178:525-530.
38. Netter P. Dopamine challenge tests as an indicator of psychological traits. Hum Psychopharmacol 2006, 21:91-99.
39. Wu S., Hsu L.A., Teng M.S., Lin J.F., Chang H.H., Chang P.Y., et al. Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals. Clin Chem Lab Med: CCLM/FESCC 2010, 48:543-549.
40. Nan H., Niu T., Hunter D.J., Han J. Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk. Cancer Epidemiol Biomarkers Prev 2008, 17:3551-3557. [cosponsored by the American Society of Preventive Oncology].
41. Platt C.I., Krekoski C.A., Ward R.V., Edwards D.R., Gavrilovic J. Extracellular matrix and matrix metalloproteinases in sciatic nerve. J Neurosci Res 2003, 74:417-429.
42. Garvin P., Nilsson L., Carstensen J., Jonasson L., Kristenson M. Plasma levels of matrix metalloproteinase-9 are independently associated with psychosocial factors in a middle-aged normal population. Psychosom Med 2009, 71:292-300.
43. Suchankova P., Baghaei F., Rosmond R., Holm G., Anckarsäter H., Ekman A. Genetic variability within the S100B gene influences the personality trait self-directedness. Psychoneuroendocrinology 2011, 36:919-923.
44. Suchankova P., Henningsson S., Baghaei F., Rosmond R., Holm G., Ekman A. Genetic variability within the innate immune system influences personality traits in women. Genes Brain Behav 2009, 8:212-217.
45. Eley T.C., Lichtenstein P., Stevenson J. Sex differences in the etiology of aggressive and nonaggressive antisocial behavior: results from two twin studies. Child Dev 1999, 70:155-168.
46. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
47. Danner M., Kasl S.V., Abramson J.L., Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med 2003, 65:347-356.
48. Williams J.E., Paton C.C., Siegler I.C., Eigenbrodt M.L., Nieto F.J., Tyroler H.A. Anger proneness predicts coronary heart disease risk: prospective analysis from the atherosclerosis risk in communities (ARIC) study. Circulation 2000, 101:2034-2039.
49. Eaker E.D., Sullivan L.M., Kelly-Hayes M., D'Agostino R.B., Benjamin E.J. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation 2004, 109:1267-1271.
50. Painuly N., Sharan P., Mattoo S.K. Relationship of anger and anger attacks with depression: a brief review. Eur Arch Psychiatry Clin Neurosci 2005, 255:215-222.
51. Mizon-Gerard F., de Groote P., Lamblin N., Hermant X., Dallongeville J., Amouyel P., et al. Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction. Eur Heart J 2004, 25:688-693.
52. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.